Company Filing History:
3 out of 8,384 
1 out of 1 Years Active: 2012-2025
Title: Paul Chang: Innovator in Cancer Treatment
Introduction
Paul Chang is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic methods. With a total of 4 patents, his work focuses on the modulation of stress granule formation and the inhibition of specific enzymes related to cancer progression.
Latest Patents
One of Paul Chang's latest patents is titled "Inhibitors of PARG." This invention relates to sulfonamides and related compounds that act as inhibitors of PARG, which are useful in the treatment of cancer. Another significant patent is "Compositions and methods for treating cancer and modulating stress granule formation." This invention provides methods for treating or decreasing the likelihood of developing stress-granule related disorders and/or cancer by administering various inhibitors and activators. The invention also outlines methods for screening agents that can treat or decrease the likelihood of developing such disorders.
Career Highlights
Throughout his career, Paul Chang has worked with prestigious organizations, including the Massachusetts Institute of Technology and Arase Therapeutics Inc. His research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Paul has collaborated with notable colleagues such as Sejal K Vyas and Anthony Leung. Their combined expertise has contributed to the development of innovative solutions in the field of cancer research.
Conclusion
Paul Chang's contributions to cancer treatment through his patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to pave the way for new therapeutic approaches that may significantly impact patient care.